Exogen Acquisition Gives Smith & Nephew Ultrasound Fracture Product
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew will add a non-invasive ultrasound fracture healing system to its orthopedic product line through the purchase of Piscataway, New Jersey-based Exogen. A definitive agreement for the $68 mil. cash deal was announced July 26.
You may also be interested in...
Smith & Nephew Exogen 2000 Labeling For Non-Union Fracture Approved
Smith & Nephew will employ its 300-person direct sales force to promote an expanded indication for the Exogen 2000 low-intensity pulsed ultrasound device for treatment of non-union bone fractures, a market valued at roughly $110 mil.
Smith & Nephew Exogen 2000 Labeling For Non-Union Fracture Approved
Smith & Nephew will employ its 300-person direct sales force to promote an expanded indication for the Exogen 2000 low-intensity pulsed ultrasound device for treatment of non-union bone fractures, a market valued at roughly $110 mil.
Smith & Nephew
Firm's recently divested bracing and support systems division, including DonJoy and ProCare orthopedics product lines, changes its name to dj Orthopedics, LLC. Sold April 30 to Chase Capital Partners, Fairfield Chase Medical Partners and senior management for approximately $202 mil., the business will focus on expanding product lines and identifying growth opportunities, including collaborations with other firms (1"The Gray Sheet" May 10, p. 23)